The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
Wickham, T. J., Mathias, P., Cheresh, D. A., & Nemerow, G. R. (1993) · Cell · doi:10.1016/0092-8674(93)90231-e · Cited by 2,199
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954
Rooijen, N. V., & Sanders, A. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90012-4 · Cited by 1,779
An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor Cells
Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fattaey, A., et al. (1996) · Science · doi:10.1126/science.274.5286.373 · Cited by 1,760
Self-citationClinical Implications of the p53 Tumor-Suppressor Gene
Harris, C. C., & Hollstein, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291807 · Cited by 1,330
Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., Gore, M., Ironside, J., MacDougall, R. H., Heise, C., et al. (2000) · Nature Medicine · doi:10.1038/78638 · Cited by 1,101
Self-citationExperimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
Martuza, R. L., Malick, A., Markert, J. M., Ruffner, K. L., & Coen, D. M. (1991) · Science · doi:10.1126/science.1851332 · Cited by 1,050
Yang, Y., Li, Q., Ertl, H. C., & Wilson, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2004-2015.1995 · Cited by 1,032
Heise, C., Sampson-Johannes, A., Williams, A., Mccormick, F., Von Hoff, D. D., & Kirn, D. H. (1997) · Nature Medicine · doi:10.1038/nm0697-639 · Cited by 940
Self-citationCrystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C.-S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T., & Danel, C. (1994) · Nature Genetics · doi:10.1038/ng0994-42 · Cited by 826
Stepwise dismantling of adenovirus 2 during entry into cells
Greber, U. F., Willetts, M., Webster, P., & Helenius, A. (1993) · Cell · doi:10.1016/0092-8674(93)90382-z · Cited by 811
Bett, A. J., Haddara, W., Prevec, L., & Graham, F. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8802 · Cited by 744
Gene Therapy for Cancer: What Have We Done and Where Are We Going?
Roth, J. A., & Cristiano, R. J. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.1.21 · Cited by 635
Yang, Y., Ertl, H. C. J., & Wilson, J. M. (1994) · Immunity · doi:10.1016/1074-7613(94)90074-4 · Cited by 611
Dai, Y., Schwarz, E. M., Gu, D., Zhang, W. W., Sarvetnick, N., & Verma, I. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1401 · Cited by 591
Rodríguez, R., Schuur, E. R., Lim, H. Y., Henderson, G. A., Simons, J. W., & Henderson, D. (1997) · PubMed · Cited by 584
Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Zhang, W. W., Owen‐Schaub, L. B., & Roth, J. A. (1994) · PubMed · Cited by 515
Ganly, I., Kirn, D. H., Eckhardt, G., Rodriguez, G. I., Soutar, D. S., Otto, R., Robertson, A. G., Park, O., Gulley, M. L., Heise, C. C., et al. (2000) · PubMed · Cited by 508
Self-citationInnate Immune Mechanisms Dominate Elimination of Adenoviral Vectors Following In Vivo Administration
Worgall, S., Wolff, G., Falck-Pedersen, E., & Crystal, R. G. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-37 · Cited by 491
Engelhardt, J. F., Ye, X., Doranz, B., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6196 · Cited by 470
Rho Family GTPases Bind to Phosphoinositide Kinases
Tolias, K. F., Cantley, L. C., & Carpenter, C. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.17656 · Cited by 466
The liposome-mediated macrophage ‘suicide’ technique
Van Rooijen, N. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90178-6 · Cited by 441
Activation of phosphoinositide 3-kinase activity by Cdc42Hs binding to p85.
Zheng, Y., Bagrodia, S., & Cerione, R. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32226-3 · Cited by 394
Barker, D., & Berk, A. J. (1987) · Virology · doi:10.1016/0042-6822(87)90441-7 · Cited by 385
Rothmann, T., Hengstermann, A., Whitaker, N. J., Scheffner, M., & zur Hausen, H. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9470-9478.1998 · Cited by 353
Freytag, S. O., Rogulski, K. R., Paielli, D. L., Gilbert, J. D., & Kim, J. H. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.9-1323 · Cited by 337
Huard, J., Lochmüller, H., Acsádi, G., Jani, A., Massie, B., & Karpati, G. (1995) · PubMed · Cited by 331
Assessment of Recombinant Adenoviral Vectors for Hepatic Gene Therapy
Li, Q., Kay, M. A., Finegold, M., Stratford-Perricaudet, L. D., & Woo, S. L. C. (1993) · Human Gene Therapy · doi:10.1089/hum.1993.4.4-403 · Cited by 305
p53 and DNA polymerase α compete for binding to SV40 T antigen
Gannon, J. V., & Lane, D. P. (1987) · Nature · doi:10.1038/329456a0 · Cited by 282
Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administration
Kay, M. A., Holterman, A.-X., Meuse, L., Gown, A., Ochs, H. D., Linsley, P. S., & Wilson, C. B. (1995) · Nature Genetics · doi:10.1038/ng1095-191 · Cited by 280
Lechner, M. S., Mack, D. H., Finicle, A. B., Crook, T., Vousden, K. H., & Laimins, L. A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05375.x · Cited by 273
Van Rooijen, N., Kors, N., Ende, M. V. D., & Dijkstra, C. D. (1990) · Cell and Tissue Research · doi:10.1007/bf00318625 · Cited by 262
Yang, Y., Xiang, Z., Ertl, H. C., & Wilson, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7257 · Cited by 260
Adenovirus Endocytosis via α v Integrins Requires Phosphoinositide-3-OH Kinase
Li, E., Stupack, D., Klemke, R., Cheresh, D. A., & Nemerow, G. R. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2055-2061.1998 · Cited by 250
Adenovirus Endocytosis Requires Actin Cytoskeleton Reorganization Mediated by Rho Family GTPases
Li, E., Stupack, D., Bokoch, G. M., & Nemerow, G. R. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8806-8812.1998 · Cited by 249
Qian, Q., Jutila, M. A., Van Rooijen, N., & Cutler, J. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5000 · Cited by 246
Wold, W. S. M., & Gooding, L. R. (1991) · Virology · doi:10.1016/0042-6822(91)90815-s · Cited by 245
Yang, Y., Trinchieri, G., & Wilson, J. M. (1995) · Nature Medicine · doi:10.1038/nm0995-890 · Cited by 242
Barr, D. M., Tubb, J., Ferguson, D., Scaria, A., Lieber, A., Wilson, C. B., Perkins, J. D., & Kay, M. A. (1995) · PubMed · Cited by 235
Kass-Eisler, A., Falck-Pedersen, E., Elfenbein, D. H., Alvira, M. R., Buttrick, P. M., & Leinwand, L. A. (1994) · PubMed · Cited by 216
Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms
Wohlfart, C. (1988) · Journal of Virology · doi:10.1128/jvi.62.7.2321-2328.1988 · Cited by 216
Wolff, G., Worgall, S., van Rooijen, N., Song, W. R., Harvey, B. G., & Crystal, R. G. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.624-629.1997 · Cited by 210
van Rooijen, N., Kors, N., & Kraal, G. (1989) · Journal of Leukocyte Biology · doi:10.1002/jlb.45.2.97 · Cited by 205
Ilan, Y., Droguett, G., Chowdhury, N. R., Li, Y., Sengupta, K., Thummala, N. R., Davidson, A., Chowdhury, J. R., & Horwitz, M. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2587 · Cited by 201
Replication-selective adenoviruses as oncolytic agents
Heise, C., & Kirn, D. H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9762 · Cited by 195
Self-citationMarshall, E. (2000) · Science · doi:10.1126/science.288.5468.951 · Cited by 194
Van Rooijen, N., & Sanders, A. (1996) · Hepatology · doi:10.1002/hep.510230544 · Cited by 188
Rac GTPase interacts specifically with phosphatidylinositol 3-kinase
BOKOCH, G. M., VLAHOS, C. J., WANG, Y., KNAUS, U. G., & TRAYNOR-KAPLAN, A. E. (1996) · Biochemical Journal · doi:10.1042/bj3150775 · Cited by 186
Goldman, M. J., & Wilson, J. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.5951-5958.1995 · Cited by 185
Early events in the interaction of adenoviruses with Hela cells
Chardonnet, Y., & Dales, S. (1970) · Virology · doi:10.1016/0042-6822(70)90189-3 · Cited by 184
Vilquin, J.-T., Guérette, B., Kinoshita, I., Roy, B., Goulet, M., Gravel, C., Roy, R., & Tremblay, J. P. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.11-1391 · Cited by 160
Zsengellér, Z. K., Wert, S. E., Hull, W. M., Hu, X., Yei, S., Trapnell, B. C., & Whitsett, J. A. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.4-457 · Cited by 147
Goodrum, F. D., & Ornelles, D. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.548-561.1997 · Cited by 138
E3 Transcription Unit of Adenovirus
Wold, W. S. M., Tollefson, A. E., & Hermiston, T. W. (1995) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-79496-4_13 · Cited by 138
O’Neal, W. K., Zhou, H., Morral, N., Aguilar-Córdova, E., Pestaner, J. P., Langston, C., Mull, B. B., Wang, Y., Beaudet, A. L., & Lee, B. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.11-1587 · Cited by 135
Circumventing the immune response to adenovirus-mediated gene therapy.
Kass-Eisler, A., Leinwand, L. A., Gall, J. G. D., Bloom, B., & Falck-Pedersen, E. (1996) · PubMed · Cited by 134
Yang, Y., Greenough, K., & Wilson, J. M. (1996) · PubMed · Cited by 131
Huitinga, I., Ruuls, S. R., JUNG, S., van Rooijen, N., Hartung, H. ‐., & Dijkstra, C. D. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03675.x · Cited by 128
Fang, B., Eisensmith, R. C., Wang, H., Kay, M. A., Cross, R. E., Landen, C. N., Gordon, G., Bellinger, D. A., Read, M. S., Hu, P. C., et al. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.8-1039 · Cited by 127
Gordon, M., Nemunaitis, J. J., Hoffman, R., Paquette, R., Rosenfeld, C. S., Manfreda, S., ISAACS, R. E., & Nimer, S. D. (1995) · Blood · doi:10.1182/blood.v85.11.3066.bloodjournal85113066 · Cited by 125
Self-citationTurnell, A. S., Grand, R. J. A., & Gallimore, P. H. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.2074-2083.1999 · Cited by 123
Ganly, I., Eckhardt, S. G., Rodriguez, G. I., et al. (2000) · Clinical Cancer Research · Cited by 123
Jooss, K. U., Ertl, H. C. J., & Wilson, J. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2945-2954.1998 · Cited by 118
You, L., Yang, C., & Jablons, D. M. (2000) · PubMed · Cited by 116
Biewenga, J., van der Ende, M. B., Krist, L. F. G., Borst, A., Ghufron, M., & van Rooijen, N. (1995) · Cell and Tissue Research · doi:10.1007/bf00304524 · Cited by 111
Association of human class I MHC alleles with the adenovirus E3/19K protein.
Beier, D. C., Cox, J. H., Vining, D. R., Cresswell, P., & Engelhard, V. H. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.8.3862 · Cited by 107
Kaplan, J. M., Armentano, D., Sparer, T. E., Wynn, S. G., Peterson, P. A., Wadsworth, S. C., Couture, K. K., Pennington, S. E., George, J. A. S., Gooding, L. R., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-45 · Cited by 103
Bai, M., Campisi, L., & Freimuth, P. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5925-5932.1994 · Cited by 96
Kozarsky, K., S, M. G. B., & Wilson, J. M. (1993) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01233250 · Cited by 84
Kupffer Cell Function in Host Defense
McCuskey, R. S., McCuskey, P. A., URBASCHEK, R., & Urbaschek, B. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.supplement_5.s616 · Cited by 66
Ultrastructural and Immunofluorescence Studies of Early Events in Adenovirus-HeLa Cell Interactions
Patterson, S., & Russell, W. C. (1983) · Journal of General Virology · doi:10.1099/0022-1317-64-5-1091 · Cited by 63
Human marrow stromal cells: response to interleukin-6 (IL-6) and control of IL-6 expression
Nemunaitis, J. J., Df, A., Mochizuki, D., Lilly, M., & Singer, J. W. (1989) · Blood · doi:10.1182/blood.v74.6.1929.1929 · Cited by 56
Self-citationFeuerbach, D., & Burgert, H.-G. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05984.x · Cited by 33
Cited by
Nonlinear Partial Differential Equations with Applications
Roubíček, T. (2013) · International Series of Numerical Mathematics · doi:10.1007/978-3-0348-0513-1 · Cited by 676
Going viral with cancer immunotherapy
Lichty, B. D., Breitbach, C. J., Stojdl, D. F., & Bell, J. C. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3770 · Cited by 581
Hu, J. C. C., Coffin, R. S., Davis, C. J., Graham, N. J., Groves, N., Guest, P. J., Harrington, K. J., James, N. D., Love, C. A., McNeish, I., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0759 · Cited by 569
Adenovirus vectors for gene therapy, vaccination and cancer gene therapy
Wold, W., & Toth, K. (2014) · Current Gene Therapy · doi:10.2174/1566523213666131125095046 · Cited by 555
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Liu, T.-C., Galanis, E., & Kirn, D. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0736 · Cited by 450
Self-citation
Metadata
- Authors
- Nemunaitis, J., Cunningham, C., Buchanan, A., Blackburn, A., Edelman, G., Maples, P., Netto, G., Tong, A., Randlev, B., Olson, S., & Kirn, D.
- Venue
- Gene Therapy
- Published
- 2001-05-01
- Volume
- 8
- Issue
- 10
- Pages
- 746-759
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2085649860
- Cited by
- 283
- References
- 73
- FWCI
- 15.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.